3-and 4-substituted 4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as potassium channel openers: synthesis, pharmacological evaluation, and structure-activity relationships. 1996

P de Tullio, and B Pirotte, and P Lebrun, and J Fontaine, and L Dupont, and M H Antoine, and R Ouedraogo, and S Khelili, and C Maggetto, and B Masereel, and O Diouf, and T Podona, and J Delarge
Laboratoire de Chimie Pharmaceutique, Université de Liége, Belgium.

4-N-Substituted and -unsubstituted 3-alkyl- and 3-(alkylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides were synthesized and tested vs diazoxide and selected 3-alykl- and 3-(alkylamino)-7-chloro-4H-1,2,4-benzothiadiazine 1,1-dioxides as potassium channel openers on pancreatic and vascular tissues. Several 4-N-unsubstituted 3-(alkylamino)pyridothiadiazines and some 3-(alkylamino)-7-chlorobenzothiadiazines were found to be more potent than diazoxide for the inhibition of the insulin-releasing process. Moreover, the 3-(alkylamino)pyridothiadiazines appeared to be more selective for the pancreatic than for the vascular tissue. By means of the pharmacological results obtained on pancreatic B-cells, structure--activity relationships were deduced and a pharmacophoric model for the interaction of these drugs with their receptor site associated to the pancreatic K(ATP) channel was proposed. According to their selectivity for the B-cell (endocrine tissue) vs the vascular (smooth muscle tissue) ionic channel, selected 3-(alkylamino)-4H-pyrido[4,3-e]-1,2,4,-thiadiazine 1,1-dioxides may serve as pharmacological tools in studying the K(ATP) channels ("pancreatic-like" K(ATP) channels) in other tissues.

UI MeSH Term Description Entries
D007082 Ileum The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008297 Male Males
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles

Related Publications

P de Tullio, and B Pirotte, and P Lebrun, and J Fontaine, and L Dupont, and M H Antoine, and R Ouedraogo, and S Khelili, and C Maggetto, and B Masereel, and O Diouf, and T Podona, and J Delarge
January 2013, Monatshefte fur chemie,
P de Tullio, and B Pirotte, and P Lebrun, and J Fontaine, and L Dupont, and M H Antoine, and R Ouedraogo, and S Khelili, and C Maggetto, and B Masereel, and O Diouf, and T Podona, and J Delarge
January 2000, European journal of medicinal chemistry,
P de Tullio, and B Pirotte, and P Lebrun, and J Fontaine, and L Dupont, and M H Antoine, and R Ouedraogo, and S Khelili, and C Maggetto, and B Masereel, and O Diouf, and T Podona, and J Delarge
May 1974, Journal of medicinal chemistry,
P de Tullio, and B Pirotte, and P Lebrun, and J Fontaine, and L Dupont, and M H Antoine, and R Ouedraogo, and S Khelili, and C Maggetto, and B Masereel, and O Diouf, and T Podona, and J Delarge
February 2008, Journal of enzyme inhibition and medicinal chemistry,
P de Tullio, and B Pirotte, and P Lebrun, and J Fontaine, and L Dupont, and M H Antoine, and R Ouedraogo, and S Khelili, and C Maggetto, and B Masereel, and O Diouf, and T Podona, and J Delarge
December 2015, Molecules (Basel, Switzerland),
P de Tullio, and B Pirotte, and P Lebrun, and J Fontaine, and L Dupont, and M H Antoine, and R Ouedraogo, and S Khelili, and C Maggetto, and B Masereel, and O Diouf, and T Podona, and J Delarge
September 1972, Journal of medicinal chemistry,
P de Tullio, and B Pirotte, and P Lebrun, and J Fontaine, and L Dupont, and M H Antoine, and R Ouedraogo, and S Khelili, and C Maggetto, and B Masereel, and O Diouf, and T Podona, and J Delarge
December 1997, Chemical & pharmaceutical bulletin,
P de Tullio, and B Pirotte, and P Lebrun, and J Fontaine, and L Dupont, and M H Antoine, and R Ouedraogo, and S Khelili, and C Maggetto, and B Masereel, and O Diouf, and T Podona, and J Delarge
November 1968, Journal of medicinal chemistry,
P de Tullio, and B Pirotte, and P Lebrun, and J Fontaine, and L Dupont, and M H Antoine, and R Ouedraogo, and S Khelili, and C Maggetto, and B Masereel, and O Diouf, and T Podona, and J Delarge
October 2002, Bioorganic & medicinal chemistry letters,
P de Tullio, and B Pirotte, and P Lebrun, and J Fontaine, and L Dupont, and M H Antoine, and R Ouedraogo, and S Khelili, and C Maggetto, and B Masereel, and O Diouf, and T Podona, and J Delarge
July 2011, Archiv der Pharmazie,
Copied contents to your clipboard!